These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 534786)

  • 1. Immune complexes and complement in rheumatoid arthritis.
    Lambert PH; Casali P; Nydegger U
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes and complement in rheumatoid arthritis.
    Duquesnoy B
    Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
    Male DK; Roitt IM
    Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
    Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
    J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The complement system].
    Lambert PH
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.
    Male D; Roitt IM; Hay FC
    Clin Exp Immunol; 1980 Feb; 39(2):297-306. PubMed ID: 7389202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes.
    Hardin JA; Steere AC; Malawista SE
    Yale J Biol Med; 1984; 57(4):589-93. PubMed ID: 6334939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid pericarditis: comparison of immunologic characteristics of pericardial fluid, synovial fluid, and serum.
    Richards AJ; Koehler BE; Broder I; Gordon DA
    J Rheumatol; 1976 Sep; 3(3):275-82. PubMed ID: 978664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immune complexes and complement components in arterial and venous blood of patients with rheumatoid arthritis.
    Steven MM; Westedt ML; Daha MR; de Vries E; Cats A
    J Rheumatol; 1986 Feb; 13(1):74-8. PubMed ID: 3701744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of circulating immune complexes in children with rheumatoid arthritis].
    Ulanova MA; Iandashevskaia SI; Aleshkin VA; Ponomareva AM; Saatova GM
    Revmatologiia (Mosk); 1989; (4):42-8. PubMed ID: 2637464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.